Ionic liquids dispersive liquid-liquid microextraction and high-performance liquid chromatographic determination of irbesartan and valsartan in human urine

Biomedical Chromatography

Volumn 27, Issue 2, 2013, Pages 254-258

  Li, Zhiling ^a   Chen, Fan ^a   Wang, Xuedong ^b   Wang, Chengjun ^a  

^a WENZHOU UNIVERSITY   (China)

^b WENZHOU MEDICAL UNIVERSITY   (China)

Author keywords

Human urine; IL DLLME HPLC; Irbesartan; Valsartan

Indexed keywords

BODY FLUIDS; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; SOLVENT EXTRACTION;

ANTIHYPERTENSIVE DRUGS; CHROMATOGRAPHIC DETERMINATION; DISPERSIVE LIQUID-LIQUID MICROEXTRACTION; HIGH-PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN URINE; HUMAN URINE SAMPLES; IONIC LIQUID DISPERSIVE LIQUID-LIQUID MICROEXTRACTION-HIGH-PERFORMANCE LIQUID CHROMATOGRAPHY; IRBESARTAN; PERFORMANCE; VALSARTAN;

IONIC LIQUIDS;

FORMIC ACID; IONIC LIQUID; IRBESARTAN; METHANOL; VALSARTAN;

ARTICLE; DISPERSION; DRUG DETERMINATION; DRUG EFFICACY; DRUG IDENTIFICATION; DRUG RETENTION; DRUG URINE LEVEL; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; LIGHT ABSORPTION; LIMIT OF DETECTION; LINEAR REGRESSION ANALYSIS; LIQUID PHASE MICROEXTRACTION; REPRODUCIBILITY; SINGLE DRUG DOSE; URINE PH; URINE VOLUME;

EID: 84871980804     PISSN: 02693879     EISSN: 10990801     Source Type: Journal    
DOI: 10.1002/bmc.2784     Document Type: Article

References (21)

1. Abdellatef HE. Extractive-spectrophotometric determination of disopyramide and irbesartan in their pharmaceutical formulation. Spectrochimica Acta Part A: Molecular and Biomolecular Spectroscopy 2007; 66: 1248-1254.
2. Baldrey S, Brodie R, Morris G, Jenkins E and Brookes S. Comparison of LC-UV and LC-MS-MS for the determination of taxol. Chromatographia 2002; 55: 187-192.
3. Berton P and Wuilloud R. Highly selective ionic liquid-based microextraction method for sensitive trace cobalt determination in environmental and biological samples. Analytica Chimica Acta 2010; 662: 155-162.
4. Bozal B, Dogan-Topal B, Ozkan S and Aboul-Enein H. Quantitative analysis of irbesartan in pharmaceuticals and human biological fluids by voltammetry. Analytical Letters 2009; 42: 2322-2338.
5. Dietz ML and Stepinski DC. Anion concentration-dependent partitioning mechanism in the extraction of uranium into room-temperature ionic liquids. Talanta 2008; 75: 598-603.
6. Ferreirós N, Iriarte G, Alonso RM and Jiménez RM. Development of a solid phase extraction procedure for HPLC-DAD determination of several angiotensin II receptor antagonists in human urine using mixture design. Talanta 2007; 73: 748-756.
7. Flesch G, Muller P and Lloyd P. Absolute bioavailability and pharmacokinetics of valsartan, an angiotensin II receptor antagonist, in man. European Journal of Clinical Pharmacology 1997; 52: 115-120.
8. Georgigta C, Sora I, Albu F and Monciu C. Comparison of a LC/MS method with a LC/UV method for the determination of metformin in plasma samples. Farmácia 2010; 58: 158-169.
9. Gonzalez L, Lopez JA, Alonso RM and Jimenez RM. Fast screening method for the determination of angiotensin II receptor antagonists in human plasma by high-performance liquid chromatography with fluorimetric detection. Journal of Chromatography. A 2002; 949: 49-60.
10. Jensen MP, Neuefeind J, Beitz JV, Skanthakumar S and Soderholm L. Mechanisms of metal ion transfer into room-temperature ionic liquids:II. The role of anion exchange. Journal of the American Chemical Society 2003; 125: 15466-15473.
11. Joseph-Charles J, Brault S, Boyer C, Langlois MH, Cabrero L and Dubost JP. Simultaneous determination of irbesartan and hydrochlorothiazide in tablets by derivative spectrophotometry. Analytical Letters 2003; 36: 2485-2495.
12. Krishnaiah CH, Raghupathi R, Ramesh K and Mukkanti K. Stability-indicating UPLC method for determination of valsartan and their degradation products in active pharmaceutical ingredient and pharmaceutical dosage forms. Journal of Pharmaceutical and Biomedical Analysis 2010; 53: 483-492.
13. Li H, Wang Y, Jiang Y, Wang J, Zhao L and Gu J. A liquid chromatography/tandem mass spectrometry method for the simultaneous quantification of valsartan and hydrochlorothiazide in human plasma. Journal of Chromatography B 2007; 852: 436-442.
14. Liu R, Liu J, Yin Y, Hu X and Jiang G. Ionic liquids in sample preparation. Analytical and Bioanalytical Chemistry 2009; 393: 871-883.
15. Lu C and Feng C. Quantitation of irbesartan and major proteins in human plasma by mass spectrometry with time-of-flight analyzer. Journal of Pharmaceutical and Biomedical Analysis 2011; 54: 100-105.
16. Malacco E, Piazza S, Meroni R and Milanesi A. Comparison of valsartan and irbesartan in the treatment of mild to moderate hypertension: a randomized, open-label, crossover study. Current Therapeutic Research 2000; 61: 789-797.
17. Mallah M, Shhmirani F and Maragheh M. Ionic liquids for simultaneous preconcentration of some lanthanoids using dispersive liquid-liquid microextraction technique in uranium dioxide powder. Environmental Science & Technology 2009; 43: 1947-1951.
18. Massie BM, Carson PE, McMurray JJ, Komajda M, McKelvie R, Anderson S, Donovan M, Iverson E and Staiger C. Irbesartan in patients with heart failure and preserved ejection fraction. The New England Journal of Medicine 2008; 359: 2456-2467.
19. McMurray JJ, Holman RR and Haffner SM. Effect of valsartan on the incidence of diabetes and cardiovascular events. The New England Journal of Medicine 2010; 362: 1477-1490.
20. Moffat AC, Osselton MD and Widdop B. Analysis of Drugs and Poisons. Pharmaceutical Press: London, 2004.
21. Zhou Q, Zhang X and Xiao J. Ultrasound-assisted ionic liquid dispersive liquid-phase micro-extraction: a novel approach for the sensitive determination of aromatic amines in water samples. Journal of Chromatography. A 2009; 1216: 4361-4365.